Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
about
Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions.Advances in the use of biologic agents for the treatment of systemic vasculitisRituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitisCurrent and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Mechanisms and markers of vascular damage in ANCA-associated vasculitis.
P2860
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@en
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@nl
type
label
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@en
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@nl
prefLabel
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@en
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@nl
P1476
Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
@en
P2093
Jason M Golbin
Ulrich Specks
P304
P356
10.1016/J.RDC.2007.09.001
P577
2007-11-01T00:00:00Z